A comprehensive view of pfizer inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer reports its experimental injectable hemophilia drug marstacimab reduced bleeding frequency without safety concerns in Phase 3 study; marstacimab works by shutting down a protein that impedes blood clotting
Published: May 31, 2023 by BioPharma Dive
Pfizer Submits Patent Application for Benzimidazole Derivatives
Published: May 31, 2023 by Pharmaceutical Patent News
US Patent Issued to Pfizer on May 30 for "Purification of antibody drug conjugates using a sodium phosphate gradient" (Massachusetts, New York, Missouri, Connecticut Inventors)
Published: May 31, 2023 by U.S. Fed News
US Patent Issued to Pfizer on May 30 for "Benzimidazole derivative compounds and uses thereof" (Connecticut, Massachusetts, Missouri, Rhode Island Inventors)
Published: May 31, 2023 by U.S. Fed News
Researchers Submit Patent Application, 'Anti-Gucy2c Antibodies And Uses Thereof', for Approval (USPTO 20230146072)
Published: May 31, 2023 by Biotech Business Daily

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count